OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06
◂ Monitor EL8 ASX

Elevate Uranium Ltd

Resource Stage · Uranium · Namibia · Australia Rating locked: sign in to view v8 · el8-20261009t155722-first-fill
Last 2026-11-06
A$0.22
1D
—
1M
—
YTD
—
1Y
—
Upside
Locked: sign in to view
Mkt cap
A$103.6M
EV
A$75.9M
Cash
A$28.8M
Debt
A$0
7 newer ASX announcements not yet reflected in this valuation

Funding, performance and ownership

Financials & Capital

As of 2026-06-30
Cash A$28.8M2025-09-30: 18,872,000 A$2025-12-31: 36,659,000 A$2026-03-31: 33,997,000 A$2026-06-30: 28,830,000 A$ Finite
Debt A$0 Net cash A$28.8M
Basic shares 471.1M 2026-09-11
Runway 5.89 quarters Audited 30 June 2026 cash A$28,820,547 divided by June-quarter Appendix 5B relevant outgoings of A$4.893 million; July A$1.1 million Marenica payment and subsequent operating burn are not reflected in the reporting-date cash.

Liquidity

Financial position

Audited cash covered about 5.9 June-quarter burn periods at 30 June. The July A$1.1 million Marenica settlement and continuing pilot, drilling and study expenditure reduce later liquidity; mine construction funding is uncommitted.

Capital structure

Ownership and dilution

Ordinary shares
471.1M
Fully diluted
498.4M

Audited 30 June 2026 ordinary shares 465,968,122 plus 4,701,659 July Marenica consideration shares equals 470,669,781. A secondary summary of the 11 September Appendix 3Y reports 390,091 rights converted to shares and 257,363 rights lapsed; this implies 471,059,872 ordinary shares. The 400,000 August 2026 options expired. Estimated unquoted options and rights now total 27,356,339, yielding 498,416,211 fully diluted shares before conditional final Marenica consideration. Confirm September Appendix 2A directly at next refresh.

Security classes14
ClassTypeQuantityStrikeExpiry
Ordinary fully paid sharesOrdinary Share471.1M——
Options expiring 30 November 2026Option7.2MA$0.722026-11-30
Retention rightsPerformance Right830KA$0—
Service rightsPerformance Right228.9KA$0—
Options expiring 8 September 2028Option70KA$0.52028-09-08
Performance rightsPerformance Right2.4MA$0—
Options expiring 13 October 2029Option2.4MA$0.652029-10-13
Options expiring 16 January 2027Option670KA$0.652027-01-16
Options expiring 20 December 2026Option3MA$0.82026-12-20
Options expiring 30 June 2028Option200KA$0.72028-06-30
Options expiring 18 July 2027Option200KA$0.452027-07-18
Options expiring 24 November 2026Option5.8MA$0.642026-11-24
Options expiring 26 February 2028Option1.5MA$0.752028-02-26
Options expiring 1 December 2029Option2.9MA$0.412029-12-01

KPI history

Operating metrics · Company

Cash at quarter end (Appendix 5B) shown
010,264,52020,529,04030,793,56041,058,080September quarter 2025: 18,872,000 AUDSeptember quarter 2025December quarter 2025: 36,659,000 AUDDecember quarter 2025March quarter 2026: 33,997,000 AUDMarch quarter 2026June quarter 2026: 28,830,000 AUDJune quarter 2026
MetricUnitTrendSeptember quarter 2025December quarter 2025March quarter 2026June quarter 2026
Cash at quarter end (Appendix 5B)AUDSeptember quarter 2025: 18,872,000 AUDDecember quarter 2025: 36,659,000 AUDMarch quarter 2026: 33,997,000 AUDJune quarter 2026: 28,830,000 AUD18,872,00036,659,00033,997,00028,830,000
Appendix 5B operating cash flowAUDSeptember quarter 2025: -2,145,000 AUDDecember quarter 2025: -3,886,000 AUDMarch quarter 2026: -2,259,000 AUDJune quarter 2026: -4,893,000 AUD(2,145,000)(3,886,000)(2,259,000)(4,893,000)
Operating metric source table13
MetricProjectPeriodPeriod typeValueStatus
Exploration spend, June quarterCompanyJune quarter 2026Quarter4,091,377 AUD exploration expenditureReported
Operating cash flow June quarterCompanyJune quarter 2026Quarter-4,893,000 AUDReported
Operating cash flow FY2026CompanyFY2026Year-12,702,085 AUDReported
Pilot Stage 1–4 mass rejectedMarenicaPilot stages 1-4 result at 31 August 2026Point In Time88 percent of feed mass rejectedReported
Pilot Stage 1–4 uranium retainedMarenicaPilot stages 1-4 result at 31 August 2026Point In Time79 percent uranium recovery to Stage 5 feedReported
Cash at quarter end (Appendix 5B)CompanySeptember quarter 2025Point In Time18,872,000 AUDReported
Appendix 5B operating cash flowCompanySeptember quarter 2025Quarter-2,145,000 AUDReported
Cash at quarter end (Appendix 5B)CompanyDecember quarter 2025Point In Time36,659,000 AUDReported
Appendix 5B operating cash flowCompanyDecember quarter 2025Quarter-3,886,000 AUDReported
Cash at quarter end (Appendix 5B)CompanyMarch quarter 2026Point In Time33,997,000 AUDReported
Appendix 5B operating cash flowCompanyMarch quarter 2026Quarter-2,259,000 AUDReported
Cash at quarter end (Appendix 5B)CompanyJune quarter 2026Point In Time28,830,000 AUDReported
Appendix 5B operating cash flowCompanyJune quarter 2026Quarter-4,893,000 AUDReported
Company guidance5
MetricProjectPeriodLowHighStatus
U Pgrade Pilot Plant Results Release TimingmarenicaStages 1-4 results released 31 August 2026; Stage 5 integrated results pending—— calendar timingAchieved
Marenica Infill Drilling Completionmarenicaearly August 2026—— calendar timingSuperseded
Integrated Steady State Operation Across All Five U Pgrade StagesmarenicaQ4 2026—— calendar timingCurrent
Pilot Plant Testing Of Koppies OrekoppiesQ1 2027—— calendar timingCurrent
Commence Marenica Scoping StudymarenicaQ1 2027—— calendar timingCurrent

Capital history

Capital events

4 events · newest first
DateEventAmountSharesPriceStatusTerms
2026-07-28Ann. 2026-07-13RaisingOrdinary Fully Paid SharesA$1.1M4.7MA$0.234CompletedNon-cash consideration for the completed first 10% Marenica ownership increase, taking current ownership to 85%.Max 4.7M · Period 2026-07-13 to 2026-07-28
2026-07-13RaisingOrdinary Fully Paid SharesA$1.1M4.6M—AnnouncedPending non-cash consideration for the remaining 5% Marenica interest; completion was extended twice and is not included in ordinary shares on issue.Max 4.6M · Period 2026-07-13 to 2026-09-30 · five-day VWAP before the extended closing date; quantity is the residual of the original maximum after the first tranche
2025-12-23RaisingOrdinary Fully Paid SharesA$2.5M8.9MA$0.28CompletedNon-cash share consideration for the completed acquisition of Uranium Generation Pty Ltd.Max 8.9M · Period 2025-12-23 to 2025-12-23
2025-11-07Ann. 2025-10-31RaisingOrdinary Fully Paid SharesA$25M71.4MA$0.35CompletedA$25 million institutional placement before costs.Max 71.4M · Period 2025-10-31 to 2025-11-07

Contracts and ownership

Material economic arrangements These are deals that can affect sales, costs, funding or ownership. An arrangement marked “Included in valuation” may already be built into a project estimate or the bridge to shareholder value. A separate amount is shown only when one can be estimated; do not add it again.

Complete As Disclosed · as of 2026-09-25

2026 annual report contingent-liability note and post-period Marenica transaction were reconciled with transaction and resource announcements. No commodity or FX derivative hedge is disclosed in the audited report.

Namibian mineral-licence introduction agreement; specific current project mapping is not named in the annual report. A$2.026 million has been paid to date, nil in FY2026.

Other · Active
Counterparties
Mallee Minerals Pty Limited
Applies to
Company-wide · Uranium
Economic direction
Burden
Period
From 2006-04-07; no end date stated
Key terms
Inferred classification fee: 0.01 AUD per tonne of ore
Indicated incremental fee: 0.02 AUD per tonne of ore
Measured incremental fee: 0.03 AUD per tonne of ore
How it affects our valuation

No valuation treatment is available for this arrangement.

A 1% gross royalty is payable to Paladin Energy on any Oobagooma production; no production to date.

Royalty · Active
Counterparties
Paladin Energy Limited
Applies to
Oobagooma Uranium Project · Uranium
Economic direction
Burden
Period
From 2019-12-13; no end date stated
Key terms
Gross production royalty: 1 percent
How it affects our valuation

No valuation treatment is available for this arrangement.

A separate 1% gross royalty is payable to Areva Mining on Oobagooma production; no production to date.

Royalty · Active
Counterparties
Areva Mining
Applies to
Oobagooma Uranium Project · Uranium
Economic direction
Burden
Period
From 2019-12-13; no end date stated
Key terms
Gross production royalty: 1 percent
How it affects our valuation

No valuation treatment is available for this arrangement.

A 1.5% gross royalty on Pamela/Angela production is embedded in the risk-adjusted project calibration.

Royalty · Active
Counterparties
Paladin NT Pty Ltd
Applies to
Angela Uranium Project · Uranium
Economic direction
Burden
Period
From 2019-12-13; no end date stated
Key terms
Gross production royalty: 1.5 percent
How it affects our valuation

No valuation treatment is available for this arrangement.

Core Lithium retains a 1% net smelter royalty over the acquired Napperby project; no production to date.

Royalty · Active
Counterparties
Core Lithium Limited
Applies to
Napperby Uranium Project · Uranium
Economic direction
Burden
Period
From 2025-12-22; no end date stated
Key terms
Net smelter royalty: 1 percent
How it affects our valuation

No valuation treatment is available for this arrangement.

Energy Metals-operated Bigrlyi joint venture; Elevate holds 20.82% of a 23.9 Mlb uranium resource and potential vanadium by-product.

Joint Venture · Active
Counterparties
Energy Metals Limited
Applies to
Bigrlyi Uranium Joint Venture · Uranium · Others
Economic direction
Mixed
Period
Dates not stated
Key terms
Elevate participating interest: 20.82 percent
How it affects our valuation

No valuation treatment is available for this arrangement.

Minority joint venture interests across Walbiri, Sundberg, Hill One, Karins and Malawiri, valued at source-reported attributable pounds.

Joint Venture · Active
Counterparties
Energy Metals Limited
Applies to
Attributable Ngalia JV resource basket · Uranium
Economic direction
Mixed
Period
Dates not stated
Key terms
Participating interest range: 20.82-23.97 percent
How it affects our valuation

No valuation treatment is available for this arrangement.

Completed Xanthos 10% acquisition increased Elevate ownership from 75% to 85%; current project calibration uses 85%.

Joint Venture · Active
Counterparties
Xanthos
Applies to
Marenica Uranium Project · Uranium
Economic direction
Benefit
Period
From 2026-07-28; no end date stated
Key terms
Acquired interest: 10 percent
Cash paid: 1,100,000 AUD
Shares issued: 4,701,659 ordinary shares
How it affects our valuation

No valuation treatment is available for this arrangement.

Final 5% acquisition had not closed by 25 September; closing deadline extended to 30 September. No present 90% project value is taken.

Joint Venture · Conditional
Counterparties
Millenium
Applies to
Marenica Uranium Project · Uranium
Economic direction
Mixed
Period
Through 2026-09-30; start date not stated
Key terms
Conditional remaining interest: 5 percent
Share consideration: 1,100,000 AUD
Debt release: 3,425,275 AUD
How it affects our valuation

No valuation treatment is available for this arrangement.

Conditional sale of Oobagooma with upfront cash, ORP shares and milestone shares; completion remained unconfirmed by the cutoff.

Other · Conditional
Counterparties
Orpheus Uranium Limited
Applies to
Oobagooma Uranium Project · Uranium
Economic direction
Benefit
Period
Dates not stated
Key terms
Upfront cash: 225,000 AUD
Upfront ORP shares: 20,000,000 shares
How it affects our valuation

No valuation treatment is available for this arrangement.